2017 American Transplant Congress Archives - Page 20 of 181

B Cells in Liver Transplant Tolerance.

M. Morita,¹ G. Asonye,¹ N. Gupta,¹ J. Fung,² C. Miller,³ S. Qian,^1,3 L. Lu.^1,3
Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes.

S. Brar, Y. Wang, A. Cannitelli, Y. Li, O. Famure, S. Husain, J. Kim.
Banff 2013 Classification of Renal Allograft Pathology Is Superior to Banff 2007 in Detecting and Managing Milder and Earlier Cases of Antibody-Mediated Rejection.

J. Hassler,¹ V. Ariyamuthu,² A. Hendricks,¹ B. Tanriover,² J. Torrealba.¹
Bariatric Operations at a Service of the Transplant Surgery.

A. Keidar,¹ R. Yemini,¹ M. Ben David,¹ E. Nesher,² J. Vinkler,³ M. Broun,² E. Mor.²
Bariatric Surgery Prior to Living Kidney Donation: A Solution to Expand the Donor Pool.

M.-T. Nguyen, D. Carpenter, A. Mathur, J. Van Bever, R. Sandoval, L. Ratner.
Barriers and Experiences When Patients Decide on a Kidney Transplant Center.

C. Schaffhausen,^1,4 M. Bruin,³ J. Synder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2,4
Barriers to Becoming Active on the Renal Transplant Waiting List: Have They Changed in the Last Five Years?

E. van Hardeveld,¹ T. Furlong,² A. Robertson,² N. Suh,² S. Thwaites,² R. Millar,² R. Masterson,¹ M. Lian,¹ B. Jones,¹ P. Hughes.¹
Baseline Immune Assessment to Individualize Immunosuppression in SPK Recipients with Type 1 Diabetes.

Y. Kudva, V. Dadlani, A. Miller, M. Abdallah, W. Kremers, M. Stegall, R. Abraham.
Belatacept After Kidney Transplantation in Adolescents.

C. Lerch, N. Kanzeleyer, T. Ahlenstiel-Grunow, K. Froede, M. Kreuzer, J. Drube, L. Pape.
Belatacept Conversion for Calcineurin Inhibitor (CNI) Toxicity: Our First 100 Patients.

R. Crew, S. Patel, A. Pai, I. Batal, H. Fernandez.